
Keywords: POAG; tPA; uPA; LRP-1; RAP; tPA-Stop; Degeneration of RGCs; POAG; Primary Open-Angle Glaucoma; IOP; intraocular pressure; tPA; tissue plasminogen activator; uPA; urokinase plasminogen activator; LRP-1; low density lipoprotein-related receptor-1; RAP; rece